US biotech firm Novavax has posted a net loss of $1.7 billion in 2021 and further posted a net loss of $182 million in the last quarter of the year. It said its forecast is “subject to significant uncertainty”, particularly with regard to future sales and funding from the US government. Novavax had over $1.5…